Abstract:Background: Regulating epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic resistance, whereas a limited number of broadly comprehensive investigations of miRNAs involved in metastatic colorectal cancer (mCRC) have been conducted. In this study, we investigated the roles and mechanisms of EMT process in mCRC. Methods: We used ISH and RT-qPCR to measure expression of miR93 in CRC tissues, nontumor tissues and metastatic liver tissues. CRC cell lines were transduced with lentiviruses expressed miR93. Its inhibitor sequence targeted miR93 or a scrambled sequence (control). Proliferation, metastasis, invasion and colony formation and growth of CRC cells which overexpress miR93 or its inhibitor in severe combined immune-deficient mice were analysed. Western blot, and luciferase assays were used to measure expression of Eph tyrosine kinase receptor (EphA4) and related signalling molecules. Results: In this study, we demonstrated that miR93 regulated EMT process by targeting EphA4 in mCRC. CRC tissues and metastatic liver tissues had increased levels of miR93 compared with the nontumor tissues and cells, and miR93 can regulate EMT process. Overexpression of miR93 increased proliferation of CRC cells, metastasis, invasion and colony formation in vitro, whereas miR93 depletion reduced these parameters. In nude mice, overexpression of miR93 by CRC cells increased liver metastasis and overexpression of the miR93 inhibitor reduced it. Then we identified by microarray analysis that the direct and functional target genes of miR93 was EphA4. Knockdown of EphA4 phenocopied the effect of miR-93 and ectopic expression of EphA4 restored the effect of miR93 on proliferation, migration, invasion and liver metastasis in CRC cells. Conclusions: Our findings revealed miR93 regulates EMT process by targeting EphA4 to affect liver metastasis in CRC. miR93 inhibited tumor metastasis by directly targeting EphA4, a crucial factor in regulating EMT. Collectively, this study provides new insights into exploring the therapeutic potential of miR93, which is able to regulate EMT process to affect tumor metastasis, and warrant further study in clinical settings. Clinical trial indentification: The present study was supported in part by grants from the Health and Family Planning Commission of Shanxi Province (No.2015049), the Applied Basic Research Programs of Shanxi Science and Technology Department (No.201601D011128). Legal entity responsible for the study: The Health and Family Planning Commission of Shanxi Province, the Applied Basic Research Programs of Shanxi Science and Technology Department Funding: The Health and Family Planning Commission of Shanxi Province, the Applied Basic Research Programs of Shanxi Science and Technology Department Disclosure: All authors have declared no conflicts of interest.

Mir-93 Regulates Epithelial-to-mesenchymal Transition Process in Metastatic Colorectal Cancer by Targeting EphA4

Micro ribonucleic acid-93 promotes oncogenesis of cervical cancer by targeting RAB11 family interacting protein 1.

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

TPPP3 Inhibits the Proliferation, Invasion and Migration of Endometrial Carcinoma Targeted with Mir-1827

Mir-106B Promotes Cell Invasion and Metastasis Via PTEN Mediated EMT in ESCC.

Mir-93-5p Inhibits the Emt of Breast Cancer Cells Via Targeting Mkl-1 and Stat3

Exosomes Derived Mir-454-3p to Promote the Progression of Colorectal Cancer Via MIER1-mediated Notch Signaling Activation.

Mir-93-5p Enhances Migration and Invasion by Targeting RGMB in Squamous Cell Carcinoma of the Head and Neck

Mir-375 Inhibits the Invasion and Metastasis of Colorectal Cancer Via Targeting SP1 and Regulating EMT-associated Genes.

Mir-93 and PTEN: Key Regulators of Doxorubicin-Resistance and EMT in Breast Cancer.

Mir-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3

MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.

MiR-29c Mediates Epithelial-to-mesenchymal Transition in Human Colorectal Carcinoma Metastasis Via PTP4A and GNA13 Regulation of Β-Catenin Signaling.

MiR-93/HMGB3 regulatory axis exerts tumor suppressive effects in colorectal carcinoma cells

Deregulation of Mir-193B Affects the Growth of Colon Cancer Cells Via Transforming Growth Factor-Β and Regulation of the SMAD3 Pathway.

Mir-93-3p Inhibition Suppresses Clear Cell Renal Cell Carcinoma Proliferation, Metastasis and Invasion.

Hypoxia-Induced Downregulation of MiR-199a-3p Promotes Proliferation, Invasion and Epithelial-Mesenchymal Transition in Colorectal Cancer Cells

The Study on Functions and Mechanisms of Mir-106b in the Metastasis of Colorectal Cancer.

Effects of miR‐93 on epithelial‐to‐mesenchymal transition and vasculogenic mimicry in triple‐negative breast cancer cells

MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells

Mir-302A Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.